SCHEMBL7400914

SCHEMBL7400914

NCc1ccc2[nH]c(Cc3nc4cc(C(=O)NCCCCc5ccccc5)ccc4[nH]3)nc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.49
POLB P06746 1/20 0.47
HTT P42858 1/20 0.47
HSP90AA1 P07900 1/20 0.47
ALDH1A1 P00352 6/20 0.46
HPGD P15428 5/20 0.46
KDM4E B2RXH2 4/20 0.46
MAPT P10636 3/20 0.46
CYP2D6 P10635 4/20 0.46
CYP2C9 P11712 4/20 0.46
CYP2C19 P33261 4/20 0.46
CYP3A4 P08684 2/20 0.46
NAMPT P43490 2/20 0.46
CYP1A2 P05177 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
IDE P14735 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GLA P06280 1/20 0.45
MLYCD O95822 1/20 0.44
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7069769 0.97 POLB (0.50) HDAC6POLBHTTALDH1A1KDM4E
Trifluoroacetic Acid SCHEMBL7067787 0.95 MLYCD (0.49) HDAC6POLBHTTHSP90AA1ALDH1A1
SCHEMBL7068309 0.93 NAMPT (0.50) HDAC6POLBALDH1A1HPGDKDM4E
SCHEMBL7073351 0.89 FLT3 (0.46) HDAC6POLBHTTALDH1A1KDM4E
SCHEMBL7075759 0.88 FLT3 (0.49) POLBHTTALDH1A1KDM4E
SCHEMBL7070258 0.87 PLAU (0.53) HDAC6POLBALDH1A1HPGDKDM4E
SCHEMBL7074425 0.86 ALDH1A1 (0.46) POLBHTTALDH1A1MAPTCYP1A2
SCHEMBL7071815 0.85 ALDH1A1 (0.44) HDAC6POLBHTTALDH1A1MAPT
SCHEMBL7075275 0.85 THRB (0.46) HDAC6POLBHTTALDH1A1MAPT
SCHEMBL7069837 0.85 ALDH1A1 (0.47) POLBHTTALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019382-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SERINE PROTEASE, PARTICULARLY TRYPTASE, ACTIVITY AXYS PHARMACEUTICALS, INC. (US) 2000-07-19 EP disclosed
WO-1998045275-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SERINE PROTEASE, PARTICULARLY TRYPTASE, ACTIVITY AXYS PHARMACEUTICALS CORPORATION (US) 1998-10-15 WO disclosed